What's its telling? Traduction is not clear thanks

Mexican local government is using it to justify a paper published by a public servant after use Ivermectin on more than 220,00 persons at Mexico City on an "almost experimental analysis". We need you help to verify, Japanese speakers friends!

Pas beaucoup de réponses...

Unfortunately, we cannot conduct clinical trials of existing drugs such as ivermectin are not possible. Expenses are necessary for large-scale clinical trials. Kitasato University is also doing it. Kowa Pharmaceutical also supports this. No approval has been submitted yet. There are few infected people in the country. According to overseas data, it is also effective for prevention. I think it would be better to do it in Japan as well. No pharmaceutical company would do this. Big companies don't do it. why. Simply put, no profit. Ivermectin was developed decades ago and the patent has expired. There are many generics. Low unit price. Even if you invest a lot in clinical trials, it will not pay off. I have this idea. Companies are not profitable even if they are approved and sold. People would prefer it if it was cheap and effective. Megapharma's strategies and human health issues must be sorted out.

However, approval of safety and off-label use of existing drugs is different from safety review of new drugs. A flexible response is required.

@@user-gl3ei7uk1t thank you so much 🙂